ArticleBalkan medical journal2025

Imiquimod and Lentigo Maligna: Can Severe Inflammation Be the Endpoint in Short-Term Use?

Seher Bostancı et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.